Description
Description
Each Owens Peptide Solutions vial contains 10mg of lyophilized Tesamorelin for qualified laboratory investigation. Tesamorelin is modeled on the complete 44-amino-acid sequence of human growth hormone-releasing factor and includes an N-terminal hexenoyl modification designed to alter peptide stability.
Research Use Disclaimer:
For laboratory and research use only. Not intended for human or animal consumption, medical use, diagnostic use, veterinary use, or therapeutic application.
In experimental systems, Tesamorelin interacts with growth hormone-releasing factor receptors associated with pituitary somatotroph signaling. Research has examined its relationship with pulsatile growth hormone release, downstream IGF-1 activity, receptor pharmacology, and hypothalamic-pituitary signaling.
Study outcomes depend on the selected model, concentration, preparation method, and analytical conditions. They should not be interpreted as directions or authorization for medical or consumer use.
Dr. Marco Vitale –
Ordered for our endocrine signalling work, packaging was appropriate for cold-chain needs.
Dr. Grace Okonkwo –
Reliable supplier so far, documentation matches the product.